Company Filing History:
Years Active: 2022
Title: Innovator Joyce Wei: Pioneering Cancer Treatment with Bispecific Antibodies
Introduction
Joyce Wei, an accomplished inventor based in New York, NY, has made significant contributions to the field of biomedical innovation. With one patented invention to her name, she is pushing the boundaries of cancer treatment through her groundbreaking research and development of bispecific antibodies.
Latest Patents
Joyce Wei's notable patent is titled "Bispecific anti-CD28 x anti-CD22 antibodies and uses thereof". This invention presents a new approach to creating bispecific antigen-binding molecules that include a first antigen-binding domain that binds specifically to human CD28 and a second domain that binds to human CD-22. The implications of this invention are profound, as these bispecific antigen-binding molecules have shown promise in inhibiting the growth of tumors that express CD-22, such as B-cell lymphomas. Furthermore, this patent outlines their potential utility in treating diseases where an induced targeted immune response may be therapeutically beneficial.
Career Highlights
Joyce Wei is currently affiliated with Regeneron Pharmaceuticals, Inc., where she continues her research in the field of immunotherapy. Her work integrates cutting-edge scientific knowledge with innovative applications, aimed at enhancing the efficacy of cancer treatments.
Collaborations
Collaboration plays a crucial role in Wei's career. She has partnered with prominent colleagues like Andrew J. Murphy and Dimitris Skokos, contributing to a collaborative environment that fosters innovative approaches to solving complex health issues.
Conclusion
In conclusion, Joyce Wei exemplifies the spirit of innovation within the biomedical field. Her invention of bispecific antibodies not only showcases her expertise as an inventor but also highlights the potential advancements in cancer treatment that can benefit countless patients. As she continues her work at Regeneron Pharmaceuticals, her contributions are sure to leave a lasting impact on the industry.